With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Featuring Alexander Dodoo
Director & Senior Research Fellow, Center for Tropical Clinical Pharmacology, University of Ghana Medical School
and Martha Gyansa-Lutterodt Program Manager, Ghana National Drugs Programme, Ministry of Health
Moderated by Rachel Nugent Senior Health Program Associate, Center for Global Development
Wednesday, March 5, 2008
at Center for Global Development
1800 Massachusetts Avenue, NW, Third Floor, Washington, DC
The problem of drug resistance is gaining increasing importance globally as greater numbers of patients in developing countries get access to needed drug therapy, delivery systems face increasing pressures and new drug pipelines can't keep up with demand. Resistance has emerged in response to treatment for AIDS, malaria, tuberculosis and other microbial infections. Health system weaknesses contributing to the problem include: stock-outs of drugs and diagnostics; lack of timely and continuous care; insufficient human resources for health; non-existent surveillance systems; substandard products; and more. These long-standing problems have become more acute with new infectious disease burdens and treatment initiatives.
Martha Gyansa-Lutterodt's presentation will focus on Ghana's national rational use of drugs programme and the positive and negative impacts of donor interventions on improving rational use of drugs, especially antimicrobials. Alexander Dodoo will then discuss the specific case of malaria where safety concerns on an ACT did lead to poor adherence and its potential impact on resistance development at the country level. Their perspectives will inform the recommendations of CGD's new Drug Resistance Working Group, which seeks to address this important global challenge.